Granulomatous variant of scleromyxedema successfully treated with topical ruxolitinib, dapsone and intravenous immunoglobulin by Donglin Zhang, BA, Kimberly Sable, MD, Allison Miller, MD, Molly Hinshaw, MD, Timothy Schmidt, MD, Bridget E. Shields, MD

Connect to this object online.